Skip to main content
. Author manuscript; available in PMC: 2013 Oct 23.
Published in final edited form as: Gene Ther. 2012 Apr 5;20(3):255–261. doi: 10.1038/gt.2012.31

Figure 3.

Figure 3

CPA suppresses host anamnestic immune response to MV in measles-immune mice. (a) Measles-immune CD46 transgenic mice were given saline or CPA according to the treatment regimens as shown in schematic diagram before re-challenge with MV-NIS i.p. (b) Anti-MV antibody (Ab) titers were measured 21 days later and plotted as fold change from starting titer (mean ± s.e.m., n = 8–26 mice per group). *Statistically different from group 1 (P<0.01, t-test).